Literature DB >> 29256981

Reconsidering Sequential Double Running Suture Removal After Penetrating Keratoplasty: A Prospective Randomized Study Comparing Excimer Laser and Motor Trephination.

Berthold Seitz1, Tobias Hager1, Achim Langenbucher2, Gottfried O H Naumann3.   

Abstract

PURPOSE: We assessed the impact of sequential double running suture removal on corneal curvature after penetrating keratoplasty (PK), comparing mechanical and nonmechanical excimer laser trephination.
METHODS: PK was performed in 134 patients (mean age 51 ± 18 yrs) using either the excimer laser [excimer, n = 60 (37 keratoconus and 23 Fuchs dystrophy)] or motor trephination [control, n = 74 (44 keratoconus and 30 Fuchs dystrophy)] and a double running cross-stitch suture. Refractometry, Zeiss keratometry, and Tomey corneal topography were performed before removal of the first suture (15.2 ± 4.2 mo) and immediately before and at least 6 weeks after removal of the second suture (21.4 ± 5.6 mo).
RESULTS: Keratometry before removal of the first (-1.7 ± 2.3 D vs. -3.1 ± 2.8 D) and second (-2.3 ± 2.6 D vs. -3.8 ± 2.8 D) sutures showed that the change in the corneal base curve was significantly smaller in the excimer group than the control group (P < 0.004). After complete suture removal, astigmatism decreased in 52% and 11%, remained stable (±0.5 D) in 27% and 9%, and increased in 21% and 80% of eyes in the excimer and control groups, respectively, resulting in significantly lower astigmatism in the excimer (3.1 ± 2.1 D) group compared with the control group (6.2 ± 2.9 D) with "all-sutures-out" (P < 0.0001). The change in vector-corrected astigmatism (Jaffe) was significantly smaller in the excimer group (4.3 ± 3.5 D) than in the control group (6.9 ± 4.5 D; P < 0.001).
CONCLUSIONS: In conclusion, less change in astigmatism and the base curve after sequential removal of a double running suture indicates better alignment of the graft in the recipient bed after excimer laser trephination. After double running suture removal, astigmatism decreases or remains unchanged in 79% of patients after excimer laser keratoplasty and increases in 80% of patients after conventional motor trephination.

Entities:  

Mesh:

Year:  2018        PMID: 29256981     DOI: 10.1097/ICO.0000000000001420

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

Review 1.  [Excimer laser-assisted penetrating keratoplasty : On 1 July 2019 excimer laser penetrating keratoplasty celebrates its 30th anniversary. Video article].

Authors:  Berthold Seitz; Loay Daas; Georgia Milioti; Nora Szentmàry; Achim Langenbucher; Shady Suffo
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

2.  Individualized Corneal Patching for Treatment of Corneal Trauma Combined with Tissue Defects.

Authors:  Ting Zhang; Yanni Jia; Suxia Li; Weiyun Shi
Journal:  J Ophthalmol       Date:  2020-11-23       Impact factor: 1.909

Review 3.  Femtosecond-Laser Assisted Surgery of the Eye: Overview and Impact of the Low-Energy Concept.

Authors:  Catharina Latz; Thomas Asshauer; Christian Rathjen; Alireza Mirshahi
Journal:  Micromachines (Basel)       Date:  2021-01-24       Impact factor: 2.891

4.  Penetrating Excimer Laser Keratoplasty with vs without the Homburg Cross-Stitch Marker in Inexperienced Surgeons.

Authors:  Shady Suffo; Mohammed El Halabi; Berthold Seitz; Alaa Din Abdin; Cristian Munteanu; Loay Daas
Journal:  Clin Ophthalmol       Date:  2021-12-07

5.  [Stage-appropriate treatment of keratoconus].

Authors:  B Seitz; L Daas; L Hamon; K Xanthopoulou; S Goebels; C Spira-Eppig; S Razafimino; N Szentmáry; A Langenbucher; E Flockerzi
Journal:  Ophthalmologe       Date:  2021-06-28       Impact factor: 1.174

6.  Repeated Femtosecond Laser-Assisted Astigmatic Keratotomies in Post-Keratoplasty Eyes.

Authors:  Nadav Levinger; Shmuel Levinger; Nir Erdinest; Asaf Achiron; Naomi London; Omer Trivizki; Eliya Levinger; Irina S Barequet
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.